Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
Clinical trial NCT02298348 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02298348
- Sponsor
- New Approaches to Neuroblastoma Therapy Consortium
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-08
- Primary completion
- 2026-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.